The notion of curing—not just preventing—cancer through food rather than therapies including drugs, radiation, chemotherapy, and surgery has been an elusive goal as scientists around the globe pursue eradication of man’s most fearful disease.

But has a startup biotech company led by a Stanford University–educated scientist and an accomplished genetics entrepreneur come up with a way of doing just that?

The company, Filtricine, has developed and already is marketing a rang…

Premium Content
You've reached your monthly limit of free articles.
Access Food Technology
Log in Subscribe

About the Author

Dale Buss, contributing editor, is an award-winning journalist and book author whose career has included reporting for The Wall Street Journal, where he was nominated for a Pulitzer Prize ([email protected]).